Keywords: Johnson & Johnson, Janssen-Cilag, Comfyde, Epilepsy, EMEA

J&J unit Janssen-Cilag withdraws MAA for Comfyde based on negative CHMP feedback

Article | 22 January 2010

Print This

Janssen-Cilag International NV, a subsidiary of US health care giant Johnson & Johns, has withdrawn its application to the European ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in